A Comparison of Prostate Biopsies Performed Before and During the COVID-19 Pandemic
| Autor: | Stjepan Frkanec, Toni Zekulić, Hrvoje Saić, Ilija Jurić, Luka Penezić, Tvrtko Hudolin, Tomislav Kuliš, Željko Kaštelan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Acta Clinica Croatica, Vol 63., Iss Supplement 2, Pp 29-33 (2024) |
| Druh dokumentu: | article |
| ISSN: | 0353-9466 1333-9451 |
| DOI: | 10.20471/acc.2024.63.s2.4 |
| Popis: | Prostate cancer is the most common cancer in men in developed countries, and prostate biopsy is the gold standard for diagnosis. However, the COVID-19 pandemic disrupted medical examinations, potentially leading to delays in diagnostic investigations, particularly for vulnerable oncology patients. This study included a total of 2796 patients. Biopsies were performed from 2018 to 2021, with a division into pre-pandemic (2018-2019) and pandemic (2020-2021) periods. To compare the two period and yearly data, we used the Chi-square test and the Cochran-Armitage trend test, respectively. During the pandemic period, there was a 26.47% decrease in prostate biopsies compared with pre-pandemic years. The percentage of patients diagnosed with GS 3+3 adenocarcinomas decreased by 37.93% and by 17.66% for GS ≥3+4 (p=0.0164). The percentage of decrease for systematic biopsy was 37.85%, while the percentage of targeted+systematic biopsy increased by 57.89% (p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|